Literature DB >> 3666976

Arteriovenous hemofiltration in children with multiple organ system failure.

G Zobel1, M Trop, E Ring, H M Grubbauer.   

Abstract

In the last year nine critically ill children with multiple organ system failure (MOSF) were treated by continuous arteriovenous hemofiltration (CAVH). The mean number of organ systems involved was five per patient (range 4 to 7). Mean duration of hemofiltration was 136 hours (range 10 to 432 h.). Mean ultrafiltration rates of 6.4 +/- 3.0 ml/m2 b.s./min achieved mean serum creatinine levels of 2.39 +/- 1.49 mg/dl. Hypervolemia and pulmonary edema were corrected rapidly by CAVH. Total parenteral nutrition with a mean caloric intake of 62 +/- 15 kcal/kg b.w./day was provided throughout the hemofiltration period. In addition high ultrafiltration rates allowed delivery of large amounts of i.v. medications. CAVH is an ideal extracorporeal renal replacement system to control azotemia, fluid, electrolyte, and acid-base status in critically ill children. It carries the potential to improve survival rate in children with MOSF.

Entities:  

Mesh:

Year:  1987        PMID: 3666976

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  4 in total

1.  Continuous arteriovenous haemofiltration and respiratory function in multiple organ systems failure.

Authors:  O N Bagshaw; F R Anaes; A Hutchinson
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Five years experience with continuous extracorporeal renal support in paediatric intensive care.

Authors:  G Zobel; E Ring; M Kuttnig; H M Grubbauer
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Haemofiltration in newborns treated with extracorporeal membrane oxygenation: a case-comparison study.

Authors:  Karin Blijdorp; Karlien Cransberg; Enno D Wildschut; Saskia J Gischler; Robert Jan Houmes; Eric D Wolff; Dick Tibboel
Journal:  Crit Care       Date:  2009-04-03       Impact factor: 9.097

4.  Blood filtration in children with severe sepsis: safe adjunctive therapy.

Authors:  J H Reeves; W W Butt
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.